Your Next Patient Has an Agent
Shopping was first. Appointments, refills and prices are next.
Aaron Uydess
Independent Principal & Founder
Key takeaways
Personal AI agents are here. Meta launched Muse on September 8 and OpenAI launched Dots on September 29, 2026. Unlike Siri, Alexa or a chatbot, they start the work themselves, remember you and keep going after you close the app.
Healthcare is the next use case, and parts are live. Gemini users can already book with 200,000+ providers through Zocdoc, and 34% of Americans have used an AI chatbot for a health reason (Pew).
The agent becomes the brand’s first audience. It reads your site, your savings terms and your competitor’s before the patient sees any of it. If an agent cannot parse your content, your brand is not in the answer.
Price and access become transparent. 57% of consumers would let an agent switch brands for better value (Checkout.com), and prescription abandonment jumps from under 5% to 60% as out-of-pocket cost rises (IQVIA).
Prepare now with three moves. Test your brand through Muse, Dots and Gemini. Make pricing, eligibility and enrollment agent-readable. Measure fills, enrollments and persistence instead of visits and opens.
Meta launched Muse on September 8. OpenAI answered with Dots on September 29. In three weeks the consumer AI conversation moved from chatbots that answer to agents that act.
Muse passed 3.4 million downloads within weeks and knocked ChatGPT off the top of the US App Store. For pharma marketers the takeaway is simple. Your patient is about to have a personal assistant, and that assistant will stand between your brand and the patient.
What they are
A personal agent is AI that knows your goals, remembers your preferences and keeps working after you close the app. Muse connects to eMail, calendar, payments, and health and fitness data. Dots plugs into more than 4,000 apps and works around the clock.
The difference from what came before is who starts the work.
Who starts the work | Memory of you | What it does | |
|---|---|---|---|
Siri, Alexa | You, one command at a time | Little | Sets the timer, plays the song |
Claude, Gemini, ChatGPT in chat | You, one prompt at a time | Some | Answers, drafts, analyzes |
Muse, Dots | The agent | Deep, across your apps | Books, buys, negotiates, follows up |
The lines are blurring. Dots lives inside ChatGPT and Google launched its own agent, Gemini Spark, in May. The direction is the same for all of them. You stop asking questions and start handing off jobs.
Why it matters to pharma
Shopping is the first use case. Healthcare is next, and parts of it are already live.
Since August, Gemini users can book appointments with more than 200,000 providers through Zocdoc without leaving the chat.
Pew found 34% of Americans use AI chatbots for health reasons. KFF puts monthly use at 29%, up from 17% in 2024.
Early Muse users report it canceling forgotten subscriptions and negotiating a lower internet bill. A pharmacy bill is not a big leap.
Neither Meta nor OpenAI is marketing prescription management today. That is my read of where this goes, and the pieces are in place. I see three implications for brands.
1. The agent becomes your first audience. It reads your site, your savings terms and your competitor's, then hands the patient a summary. If it cannot parse your content, your brand is not in the answer. One projection shared at Reuters Events Pharma 2026 has organic traffic to pharma websites falling about 50% by 2028.
2. Price and access become transparent. An agent compares the copay card, the cash price and the direct-to-patient option in seconds. IQVIA found prescription abandonment runs under 5% at zero out-of-pocket cost and 60% above $500. In a Checkout.com survey of 12,005 consumers, 57% would let an agent switch brands for better value. A prescription switch still needs a prescriber, but the agent will tee up that conversation.
3. Adherence moves from your CRM to their agent. Refill reminders, appointment prep and prior authorization follow-up become the agent's job. Your CRM eMails get triaged by an agent before a person sees them.
HCPs are on the same path. The AMA reports 81% of physicians now use AI professionally, up from 38% in 2023. Dots launched inside Slack and Teams, so expect physician agents that screen rep eMails, summarize clinical data and chase access paperwork.
Trust is the brake. Amazon blocked Muse from its store 12 days after launch, and 71% of Americans told Pew that AI will make personal information less secure. Adoption in health will trail shopping. It will still come.
How to prepare
Test your brand through an agent. Give Muse, Dots and Gemini real patient jobs: find the lowest price, enroll in the savings program, book a visit. Write down where they fail and where they get your brand wrong.
Make access agent-ready. Publish pricing, eligibility and enrollment steps as structured, label-consistent content an agent can read and act on. Decide now whether your hub and copay portals welcome agents or block them, and bring MLR, legal and privacy in early.
Change what you measure. Site visits and eMail opens will fall as agents do the reading. Measure fills, enrollments and persistence.
9 times out of 10 the agent will pick the brand that is easiest to understand, trust and act on. Start with one brand and one patient job this quarter.
CONTACT US TODAY
The first conversation is twenty-five minutes — a diagnostic, not a pitch. Pick a time with Aaron below, or send us a note about what you’re working on.
About Kairos Meridian
Kairos Meridian provides pharma strategy, marketing, and analytics in service of impact… with a dose of innovation. We serve as the senior, independent partner for pharma brands, for vendors that sell into them, and for the private equity firms making decisions about pharma-related assets.
Kairos Meridian, where strategy meets the moment, provides big agency thinking with boutique agility. We serve as strategist, operator and the additional arms & legs our clients need to hit and exceed goals.
Tagged
Go To Market Strategy & Optimization
Omnichannel
Strategy
DTP
FAQ
Have questions?
Check out the FAQs
What does Kairos Meridian do?
We do the senior commercial work pharma brands need while the decisions are still open: building the strategy, sharpening the program and running it with the analytics to prove it. The work is our product.
What are your areas of expertise?
Commercial strategy in pharma & life sciences, with the deepest work in omnichannel, direct-to-patient, innovation, data and analytics.
What kind of businesses do you work with?
Small and mid-cap pharma brands in their first five years, the vendors selling into them, and the private equity firms holding related assets.
What don’t you do?
We don’t sell technology or media, and we don’t do the technical build: no media buying, campaign production or platform implementation, and no junior consultants doing the thinking. We take strategy through execution and bring the analytics to measure it, which keeps our work independent.
Are you a fractional executive service?
No. Fractional arrangements sell a percentage of someone’s time. We take interim leadership roles with a specific mandate, a defined goal, and an end date.
How do you price your projects?
Fixed fee, scoped to the question, the weight of the answer and operated with efficiency. Our pricing is not based on hours, headcount, and agency overhead.
The first conversation is twenty-five minutes — a diagnostic, not a pitch.
Start a conversation today
We listen for the real problem — how you got here, what you’ve tried, what success looks like — then come back with a structured read. The gap between the call and the response is where the senior judgment gets applied.